Azathioprine in severe adult atopic dermatitis: A double-blind, placebo-controlled, crossover trial

British Journal of Dermatology

Volumn 147, Issue 2, 2002, Pages 324-330

  Berth Jones, J ^a,c   Takwale, A ^a   Tan, E ^a   Barclay, G ^a   Agarwal, S ^a   Ahmed, I ^a   Hotchkiss, K ^a   Graham Brown, R A C ^b  

^a GEORGE ELIOT HOSPITAL   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

^c WALSGRAVE HOSPITAL   (United Kingdom)

Author keywords

Atopic dermatitis; Atopic eczema; Azathioprine; Clinical trial; Placebo control

Indexed keywords

AZATHIOPRINE; LIVER ENZYME; PLACEBO;

ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BACKACHE; BLOOD CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DISEASE ACTIVITY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FOLLICULITIS; GASTROINTESTINAL SYMPTOM; HAY FEVER; HEADACHE; HUMAN; HUMAN CELL; IMPETIGO; LETHARGY; LEUKOPENIA; MALAISE; MALE; MIGRAINE; NAUSEA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP DISORDER; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VISUAL ANALOG SCALE; VOMITING; WORK;

ADOLESCENT; ADULT; AGED; AZATHIOPRINE; CROSS-OVER STUDIES; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOPENIA; LIVER; MALE; MIDDLE AGED;

EID: 0036378083     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04989.x     Document Type: Article

References (20)

1. Reitamo S, Rustin M, Ruzicka T et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002; 109: 547-55.
2. Luger T, van Leent EJM, Graeber M et al. SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. Br J Dermatol 2001; 144: 788-94.
3. George SA, Bilsland DJ, Johnson BE, Ferguson J. Narrow-band (TL-01) air-conditioned phototherapy for severe adult atopic dermatitis. Br J Dermatol 1993; 128: 49-56.
4. Morison WL, Parrish JA, Fitzpatrick TB. Oral psoralen photochemotherapy of atopic eczema. Br J Dermatol 1978; 98: 25-30.
5. Atherton DJ, Carabott F, Glover MT, Hawk JL. The role of psoralen photochemotherapy (PUVA) in the treatment of atopic eczema in adolescents. Br J Dermatol 1988; 118: 791-5.
6. Sowden JM, Berth-Jones J, Ross J et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991; 338: 137-40.
7. Berth-Jones J, Finlay AY, Zaki I et al. Cyclosporin in severe childhood atopic dermatitis: a multicentre study. J Am Acad Dermatol 1996; 34: 1016-21.
8. Tan BB, Lear JT, Gawkrodger DJ, English JSC. Azathioprine in dermatology: a survey of current practice in the U.K. Br J Dermatol 1997; 136: 351-5.
9. Morrison JGL, Schulz EJ. Treatment of eczema with cyclophosphamide and azathioprine. Br J Dermatol 1978; 98: 203-7.
10. August PJ. Azathioprine in the treatment of eczema and actinic reticuloid. Br J Dermatol 1982; 107 (Suppl. 22): 23.
11. Lear JT, English JSC, Jones P, Smith AG. Retrospective review of the use of azathioprine in severe atopic dermatitis. J Am Acad Dermatol 1996; 35: 642-3.
12. Buckley DA, Baldwin P, Rogers S. The use of azathioprine in severe adult atopic eczema. J Eur Acad Dermatol 1998; 11: 137-40.
13. Chu AC. The role of systemic therapy in atopic eczema. CME Bull Dermatol London: Rila Publications Ltd 1999; 2: 23-8.
14. Meggitt SJ, Reynolds NJ. Azathioprine for atopic dermatitis. Clin Exp Dermatol 2001; 26: 369-75.
15. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92 (Suppl.): 44-7.
16. Berth-Jones J. Six Area Six Sign AD (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996; 135 (Suppl. 48): 25-30.
17. Berth-Jones J, Graham-Brown RAC, Marks R et al. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis. Br J Dermatol 1997; 136: 76-81.
18. Anstey A. Azathioprine in dermatology: a review in the light of advances in understanding methylation pharmacogenetics. J R Soc Med 1995; 88: 155P-160P.
19. Holme SA, Dudley J, Anstey AV. Thiopurine methyltransferase screening prior to azathioprine treatment in the United Kingdom. Br J Dermatol 2001; 145 (Suppl. 58): 12.
20. Snow JL, Gibson LE. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients. Arch Dermatol 1995; 131: 193-7.